Advertisement

Topics

Cagent Vascular Company Profile

03:18 EDT 19th June 2019 | BioPortfolio

Cagent Vascular is leading the way for next generation technology for vessel dilatation. It is the second cardiovascular company formed by co-founders Carol Burns, President & CEO, Peter Schneider, MD, Vascular Surgeon, Chief Medical Officer and Robert Giasolli, VP of Research and Development. Visit www.cagentvascular.com for more information.


News Articles [260 Associated News Articles listed on BioPortfolio]

Vascular Surgery for Gun Injuries Carries Higher Mortality Risk

FRIDAY, May 3, 2019 -- Vascular surgery after a firearm injury is associated with an increased risk for complications and mortality, according to a study published in the May issue of the Journal of V...

Transcription factor TEAD1 is essential for vascular development by promoting vascular smooth muscle differentiation

Series D brings in an initial $25mm for Intact Vascular

Intact Vascular Inc. (minimally invasive devices for peripheral vascular procedures) raised $25mm through its Series D financing led by Vensana Capital, which was joined by returning shareholders New ...

Merit Medical Systems buys medical devices maker Vascular Insights

Based in Quincy of Massachusetts, Vascular Insights is engaged in the design, development and manufacturing and marketing of medical devices for the minimally invasive treatment of peripheral vascular...

SVS Foundation: Be 'Circulation Smart' - Know what it takes to have a healthy vascular system

CHICAGO, Jan. 9, 2019 /PRNewswire/ -- If this is the year you hope to take charge of your heath, knowing the signs of vascular disease Read more...

Gene expression analysis of vascular pathophysiology related to anti-TNF treatment in rheumatoid arthritis

Impaired vascular pathophysiology and increased cardiovascular (CV) mortality are associated with rheumatoid arthritis (RA). To date, no genomic analysis of RA- and RA treatment-related vascular patho...

FDA approves Intact Vascular’s Tack Endovascular System

Intact Vascular, Inc., a private medical device company committed to developing solutions for minimally invasive peripheral vascular procedures, today announced it received U.S. Food and Drug Administ...

Velano Vascular Raises $10M for FDA-Cleared Needle-Free Blood Draw Device

Velano Vascular, a San Francisco, CA-based vascular access technology innovator today announced that it has raised $10 million from strategic investor Intermountain Healthcare following the system’s...

Drugs and Medications [0 Results]

None

PubMed Articles [1137 Associated PubMed Articles listed on BioPortfolio]

Current vascular allograft procurement, cryopreservation and transplantation techniques in the Czech Republic.

Vascular allotransplantations are performed worldwide in selected patients suffering from vascular prosthesis infection or critical limb ischemia. Either fresh or cryopreserved vascular allograft may ...

Contribution of acid sphingomyelinase to angiotensin II-induced vascular adventitial remodeling via membrane rafts/Nox2 signal pathway.

Vascular adventitial fibroblasts (AFs) in the vascular remodeling during atherosclerosis are increasing arousing attention. Acid sphingomyelinase (ASM) is a soluble glycoprotein which is involved in t...

Vascular access complications in Extracorporeal Membrane Oxygenation: a joint effort of intensivists and vascular surgeons.

Vascular Biomaterial Banking in Academia.

To establish a high-quality vascular biomaterial bank to serve vascular research teams and act as a basis for translational medicine. The aim was to collect and store material so that investigation in...

Development of a puncture technique for implanting temporary vascular shunts in a porcine model.

Temporary vascular shunts (TVS) are an effective tool for rapidly restoring blood flow to a limb or organ that has experienced vascular injury and ischemia, and for which revascularization is not an i...

Clinical Trials [2169 Associated Clinical Trials listed on BioPortfolio]

Patient Comfort With Vascular Closure

The purpose of this research study is to collect information on the amount of discomfort patients experience with one of two different vascular blood vessel closure devices, the MynxM5 Vas...

Clinical Study of POSS-PCU Vascular Grafts for Vascular Access

This study evaluates the safety and performance of a new vascular graft made of POSS-PCU as a vascular access conduit for haemodialysis. 30 patients requiring access for dialysis will be e...

Perioperative Aspirin Response in Patients Undergoing Vascular Surgery

Reduced antiplatelet activity (low response (LR)/high on-treatment platelet reactivity (HPR)) of aspirin (ALR) or clopidogrel (CLR) is associated with an increased risk of thromboembolic e...

A Feasibility Study Evaluating the Use of SafeBreak Vascular in the Geriatric Trauma Population

SafeBreak Vascular is a medical device indicated for fluid flow control during the administration of IV fluids/medication to the patient's vascular system and to aid in the prevention of u...

Study to Evaluate Safety & Effectiveness of Vascular Sealant System

To evaluate a new vascular sealant compared to control for the control of suture line bleeding after vascular reconstructive surgery.

Companies [334 Associated Companies listed on BioPortfolio]

Cagent Vascular, LLC

Cagent Vascular is leading the way for next generation technology for vessel dilatation. It is the second cardiovascular company formed by co-founders Carol Burns, President and C...

Cagent Vascular

Cagent Vascular is leading the way for next generation technology for vessel dilatation. It is the second cardiovascular company formed by co-founders Carol Burns, President & CEO...

LeMaitre Vascular

LeMaitre Vascular is a leading global provider of innovative devices for the treatment of peripheral vascular disease. We develop, manufacture, and market disposable and implantable vascular devices t...

The Foundation for Accelerated Vascular Research

The Foundation for Accelerated Vascular Research is a non-profit medical organization dedicated to accelerating research into the cause, prevention and treatment of vascular disease. Founded in 19...

Society for Vascular Surgery

The Society for Vascular Surgery (SVS) is a not-for-profit professional medical society, composed primarily of vascular surgeons, that seeks to advance excellence and innovation in vascular health thr...

More Information about "Cagent Vascular" on BioPortfolio

We have published hundreds of Cagent Vascular news stories on BioPortfolio along with dozens of Cagent Vascular Clinical Trials and PubMed Articles about Cagent Vascular for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cagent Vascular Companies in our database. You can also find out about relevant Cagent Vascular Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Vascular
Vascular relates to blood vessels (Oxford Medical Dictionary) and can be used to describe the supply of blood, a disease affecting the blood vessels or molecules associated with these structures. For example, <!--LGfEGNT2Lhm-->atherosclerosis ...


Corporate Database Quicklinks



Searches Linking to this Company Record